Anti-Interleukin 6-receptor (IL6R) nanobody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Anti-Interleukin 6-receptor (IL6R) nanobody, covering 2019-01-04 to 2019-01-04. Get the full timeline:
Most recent: Clinical Trial Update: Study to Assess Safety and Efficacy of Anti-Interleukin 6-receptor (IL6R) Nanobody in Rheumatoid Arthritis (RA) Patients [Phase 1, Phase 2]